Recent Finacing
Recent Raise
Rebiotix develops Microbiota Restoration Therapy biologics that transplant live human-derived microbes; lead product RBX2660 is a microbiota suspension in clinical development as a non-antibiotic treatment for recurrent Clostridium difficile.
Focus Areas
Total Raised
Funding round